Dysphagia Knowledge Hub — 吞嚥困難知識庫

Tracheostomy and Dysphagia — Swallowing Management in Tracheostomised Patients

TL;DR: Dysphagia affects roughly half of tracheostomised patients, though the tracheostomy itself is not the sole cause — underlying critical illness, prolonged intubation, and neuromuscular injury drive most swallow impairment. Evidence since 2005 (Ding & Logemann) supports cuff deflation during meals where safe, and use of a one-way speaking valve (Passy-Muir type) to restore subglottic pressure and improve swallow mechanics. The modified Evans blue-dye test is a crude screen with false-negative rates up to 50 %; FEES (fibreoptic endoscopic evaluation of swallowing) is the gold standard for trach swallow assessment and decannulation readiness.

Why tracheostomy matters for swallowing

A tracheostomy is a surgical opening through the anterior neck into the trachea, usually placed to bypass upper-airway obstruction, facilitate prolonged mechanical ventilation, or manage copious secretions. Tracheostomy is not rare in Asia: Taiwan’s Respiratory Care Ward (呼吸照護病房, RCW) system under the National Health Insurance long-term ventilator care bundle has tens of thousands of tracheostomised patients at any given time, the majority of whom have some degree of dysphagia requiring formal evaluation (Taiwan 衛福部, mohw.gov.tw).

Three mechanical changes occur once a tracheostomy tube is in place:

1. Loss of subglottic pressure. Normally the vocal folds close during the swallow, generating about 5–15 cmH₂O of subglottic pressure that supports hyolaryngeal excursion and triggers the reflexive swallow. With an open tracheostomy, airflow is diverted below the vocal folds and this pressure escapes. Passy-Muir clinical data show that subglottic pressure drops to near zero when the trach is uncapped; a one-way speaking valve restores it to roughly 80 % of normal values (Passy-Muir clinical education, passy-muir.com).
2. Impaired laryngeal elevation. The inflated cuff tethers the trachea and restricts upward/forward movement of the hyolaryngeal complex — the motion that clears the airway during the pharyngeal phase. Ding and Logemann’s 2005 videofluoroscopic study in Head & Neck demonstrated significantly more aspiration and pharyngeal residue with the cuff inflated compared with the same patients’ cuff deflated (Ding & Logemann 2005, PMID 15952194).
3. Reduced laryngeal sensation and cough drive. Disuse of the upper airway blunts sensory feedback and the reflexive cough — increasing the risk of silent aspiration.

Leder and Ross’s 2010 cohort in Dysphagia is frequently cited as a corrective to the older dogma that “tracheostomy causes aspiration”: in their series, aspiration rates were not significantly different between trach and non-trach patients matched for underlying disease (Leder & Ross 2010, PMID 19856026). The modern view is that trach is a marker of critical illness and sarcopenia, not the primary driver of dysphagia — but the tube still materially affects swallow biomechanics and must be managed.

How common is dysphagia in tracheostomised patients?

Skoretz and colleagues published a scoping review in Critical Care Medicine in 2020 covering post-ICU trach patients. Prevalence estimates ranged widely — 11 % to 93 %, depending on case-mix and definition — with a pooled estimate around half of critically-ill tracheostomised survivors meeting diagnostic criteria for dysphagia (Skoretz 2020, PMID 31939810).

Subpopulation rates are clinically useful:

• Post-stroke patients with trach: 50–70 % dysphagia at the time of placement.
• Head and neck cancer patients post-surgical trach: aspiration in 30–50 %; silent aspiration in up to 40 % (limiting usefulness of bedside-only screens).
• Post-ICU / post-intubation cohort: Frajkova and colleagues reported high rates of postintubation dysphagia in COVID-19 survivors in Dysphagia in 2020 — ICU-acquired weakness, prolonged intubation (>48 h), and reintubation were key risk factors (Frajkova 2020, PMID 32556679).

The take-home for caregivers and clinicians: assume dysphagia is present in any newly-tracheostomised patient until formally ruled out.

The cuff debate — inflated or deflated for oral intake?

Historic practice in many ICUs was to keep the cuff inflated continuously to “prevent aspiration.” Evidence since the early 2000s has reversed this view for most stable patients:

• Ding and Logemann (2005) showed aspiration was more common with the cuff inflated on VFSS.
• Suiter, McCullough, and Powell (2003) in Dysphagia showed that cuff deflation plus a one-way speaking valve improved swallow biomechanics in a subset of patients, with reduced pharyngeal residue and fewer penetration events (Suiter 2003, PMID 14571331).

Current best practice (as codified in the Royal College of Speech and Language Therapists’ tracheostomy guidance and ASHA’s Practice Portal): attempt cuff deflation before any oral trial, provided the patient tolerates secretions, has an effective cough, and the ventilation mode permits it. Pooled subglottic secretions should be suctioned before deflation to avoid aspiration of the pool itself (RCSLT, rcslt.org; ASHA, asha.org).

Cuff deflation is contraindicated or requires caution when the patient has high ventilator requirements that depend on cuff seal, recent upper-airway surgery, unmanaged copious oral secretions, or inability to protect the airway.

Passy-Muir valve and swallowing

A Passy-Muir Valve (PMV) is a bias-closed one-way valve that attaches to the hub of the tracheostomy tube. It opens during inspiration, allowing air in through the trach, and closes during expiration so that exhaled air is redirected up through the vocal folds. The mechanical effects are substantial:

• Restores subglottic pressure to approximately 80 % of physiological values (Passy-Muir clinical education).
• Recovers laryngeal sensation by restoring upper-airway airflow and olfaction.
• Improves cough and secretion clearance.
• Facilitates voicing — the most recognised benefit, and often the patient’s primary motivation.
• May improve the swallow — via sensory restoration and subglottic pressure, though individual response varies.

Absolute rule: the cuff must be fully deflated before any PMV trial. Placing a PMV on an inflated cuff creates a closed system with no exhalation route — this can cause suffocation and has been associated with patient deaths. Every nurse, therapist, and family caregiver involved in PMV care must be trained in this check (RCSLT position paper; Dikeman & Kazandjian, Communication and Swallowing Management of Tracheostomised and Ventilator-Dependent Adults, 3rd ed., Plural Publishing).

Bedside screening — the modified Evans blue-dye test

The modified Evans blue-dye test (MEBD) is a practical bedside screen. The patient swallows food or water coloured with blue food dye; the trach is then suctioned and the secretions inspected for blue staining, which indicates aspiration.

MEBD is attractive — it is cheap, fast, and repeatable — but its diagnostic accuracy is limited. Béchet and colleagues’ 2016 systematic review in Dysphagia found pooled sensitivity of 38–82 %, with a false-negative rate as high as 50 % when compared with FEES or VFSS (Béchet 2016, PMID 27461481). Earlier work by Brady and colleagues (1999) in the same journal raised similar concerns (Brady 1999, PMID 10341110).

Practical interpretation:

• A positive MEBD (blue staining) is meaningful — it is unlikely to be a false positive and should trigger nil-by-mouth and instrumental assessment.
• A negative MEBD does not rule out aspiration. Silent aspiration and small-volume aspiration may not reach the trach stoma, or blue dye may be diluted below the visual detection threshold.
• MEBD is therefore a screen, not a diagnostic test. If dysphagia is suspected, proceed to FEES or VFSS.

FEES — the standard for trach swallow assessment

Fibreoptic endoscopic evaluation of swallowing is now the preferred instrumental assessment for tracheostomised patients. A flexible endoscope is passed transnasally to visualise the pharynx and larynx during trial swallows of food and liquid — dyed with a distinguishable colour — while the examiner observes penetration, aspiration, residue, and sensation.

Sensitivity for aspiration in trach patients is reported at 87–100 %, superior to MEBD. FEES is bedside-portable, does not require ionising radiation, can be repeated often, and — critically in a trach context — tolerates cuff deflation, suctioning, and PMV trials in the same session.

Warnecke and colleagues’ 2013 FEES-based decannulation protocol in Critical Care Medicine demonstrated a negative predictive value above 95 % for safe decannulation in neurocritically-ill patients (Warnecke 2013, PMID 23660728). Taiwan’s 台灣耳鼻喉頭頸外科醫學會 and 台灣咽喉科醫學會 have published FEES credentialing pathways consistent with this approach (otol.org.tw; twslhn.org.tw).

Decannulation — readiness, not a race

Decannulation — removal of the tracheostomy tube — is the structural goal for most patients. Readiness is multidimensional. A common synthesis of international criteria includes:

• Underlying reason for the trach has resolved or is stable.
• Cuff deflation tolerated for 24–72 hours continuously.
• PMV tolerated during waking hours without distress.
• Secretions manageable — suctioning required less often than every 2 hours, and the patient has an effective cough.
• FEES (or at minimum a structured bedside assessment) confirming safe swallow with manageable residue and no overt aspiration.
• Capping trial tolerated — for example 24 hours of capping the trach with no oxygen-saturation drop or respiratory distress.

The Warnecke FEES algorithm and the Global Tracheostomy Collaborative multidisciplinary care bundles (globaltrach.org) are reasonable starting frameworks for units without their own protocol. Taiwan RCW units typically follow an NHI-defined weaning pathway with mandatory SLP-led dysphagia screening before decannulation.

Common mistakes and pitfalls

• Trusting a negative MEBD. As discussed, the false-negative rate is substantial; silent aspiration frequently escapes the blue-dye test.
• Leaving the cuff inflated during meals “to be safe.” Unless there is a specific contraindication, cuff inflation during oral intake likely worsens aspiration rather than preventing it (Ding & Logemann 2005).
• Placing a PMV on an inflated cuff. A never-event. Every shift handover should include a deflation check before PMV use.
• Feeding by mouth without SLT/SLP assessment in a newly-trached ICU graduate. Silent aspiration rates are high; bedside clinical exam alone misses 40–60 % of aspirators.
• Rushing decannulation because the bed is needed. A failed decannulation — requiring re-cannulation — is traumatic and carries aspiration pneumonia risk.
• Ignoring oral hygiene. Trach patients have reduced oral clearance; poor oral hygiene and bacterial load are the strongest modifiable predictors of aspiration pneumonia (see our companion article on oral care and aspiration pneumonia prevention).
• Assuming the trach itself is the problem. Address the underlying neuromuscular, structural, or critical-illness drivers of dysphagia — do not wait for decannulation to begin rehabilitation.

What caregivers and families can ask for

If a family member has a tracheostomy and is being fed by mouth, or is being considered for oral intake, reasonable questions to ask the team include:

• Has a speech-language therapist formally assessed the swallow?
• Is there an instrumental study — FEES or VFSS — on record, or has one been planned?
• What is the cuff status during meals? Is deflation being trialled?
• Has a PMV been considered for daytime use?
• What is the plan for decannulation, and what milestones are we working toward?
• Who supervises meals, and what is the protocol if the patient coughs or desaturates?

Citations and sources

• Ding R, Logemann JA. Swallow physiology in patients with trach cuff inflated or deflated: a retrospective study. Head Neck 2005;27(9):809–13. PubMed 15952194
• Skoretz SA et al. Investigating swallowing and tracheostomy following critical illness: a scoping review. Crit Care Med 2020;48(2):e141–e151. PubMed 31939810
• Suiter DM, McCullough GH, Powell PW. Effects of cuff deflation and one-way tracheostomy speaking valve on swallowing. Dysphagia 2003;18(4):284–92. PubMed 14571331
• Leder SB, Ross DA. Confirmation of no causal relationship between tracheotomy and aspiration. Dysphagia 2010;25(1):35–9. PubMed 19856026
• Brady SL, Hildner CD, Hutchins BF. Simultaneous videofluoroscopic swallow study and modified Evans blue dye procedure. Dysphagia 1999;14(3):146–9. PubMed 10341110
• Béchet S et al. Diagnostic accuracy of the modified Evans blue dye test. Dysphagia 2016;31(6):721–729. PubMed 27461481
• Warnecke T et al. Standardized endoscopic swallowing evaluation for tracheostomy decannulation in critically ill neurologic patients. Crit Care Med 2013;41(7):1728–32. PubMed 23660728
• Frajkova Z et al. Postintubation dysphagia during COVID-19 outbreak. Dysphagia 2020;35:549–557. PubMed 32556679
• Royal College of Speech and Language Therapists — Tracheostomy clinical guidance. rcslt.org
• American Speech-Language-Hearing Association — Tracheostomy and Ventilator Dependence Practice Portal. asha.org
• Passy-Muir clinical education — valve mechanics and subglottic pressure evidence. passy-muir.com
• Dikeman KJ, Kazandjian MS. Communication and Swallowing Management of Tracheostomised and Ventilator-Dependent Adults (3rd ed). Plural Publishing.
• Global Tracheostomy Collaborative — multidisciplinary care bundles. globaltrach.org
• Taiwan 衛生福利部 — 呼吸照護病房 (RCW) and long-term ventilator care framework. mohw.gov.tw
• 台灣耳鼻喉頭頸外科醫學會 and 台灣咽喉科醫學會 — FEES guidance. otol.org.tw, twslhn.org.tw

This article paraphrases publicly-available clinical guidelines and peer-reviewed research. For clinical practice, refer to current official documentation and a qualified speech-language therapist / speech-language pathologist. This page is not medical advice.

---

Last updated: 2026-04-20 · License: CC BY 4.0 · Maintained by SeniorDeli (Carewells) — a Hong Kong social enterprise producing IDDSI-compliant care food for people living with dysphagia. This page is educational only; see About for our clinical partners and social mission.